In the previous article, we introduced strategies for mutant library construction in directed evolution, the foundation for generating enzyme variants with improved performance. However, creating a diverse mutant library is only the first step.
The success of enzyme engineering ultimately depends on another critical factor:
How efficiently can functional variants be identified from millions of candidates?
With advances in synthetic biology, automation, and high-throughput technologies, enzyme screening has evolved from traditional microbial selection approaches to powerful platforms capable of analyzing millions of variants with improved speed, sensitivity, and precision.
Based on where enzyme activity is evaluated, screening technologies can generally be classified into two categories:
- In vivo screening
- In vitro screening
Each strategy offers unique advantages and is selected according to enzyme characteristics, library size, and engineering objectives.
1. In Vivo Screening: Linking Enzyme Activity to Cellular Performance
Traditional Strain-Based Screening
The OG approach. You link your enzyme's activity to something the host cell needs to survive — growth rate, antibiotic resistance, or a visible color change. If the enzyme does its job, the colony thrives. If not, it doesn't show up on the plate.
It's elegant in its simplicity, but there's a catch: microbes are resourceful. They can reroute metabolic fluxes or activate compensatory pathways, meaning a surviving colony might owe its success to something other than your target enzyme.
PACE: Accelerating Continuous Enzyme Evolution
One breakthrough in in vivo screening is Phage-Assisted Continuous Evolution (PACE), developed by David Liu’s laboratory in 2011.
PACE connects enzyme activity with bacteriophage propagation, enabling continuous selection and evolution. In the PACE system:
- The target enzyme gene replaces the phage gene required for infectivity.
- Improved enzyme activity promotes production of functional phage particles.
- Variants with enhanced activity become enriched over successive generations.
PACE also integrates a mutagenesis plasmid (MP), allowing continuous accumulation of mutations and accelerating evolutionary cycles.
This technology has been successfully applied to engineer:
- RNA polymerases
- Proteases
- tRNA synthetases
- DNA-binding proteins
However, PACE is mainly suitable for proteins whose activity can be directly linked to phage propagation, limiting its application for some enzyme classes.
Figure 1. Phage-assisted continuous evolution (PACE) system.
Adapted from DOI: 10.1038/s41596-020-00410-3.
2. In Vitro Screening: Direct Evaluation of Enzyme Performance
Unlike in vivo screening, in vitro screening directly measures enzyme activity outside living cells.
The general workflow includes:
- Expression of enzyme variants
- Protein extraction or secretion
- Enzyme-substrate reaction
- Detection of product formation or physical changes
- Identification of improved variants
Traditional in vitro screening methods rely on: Tube-based assays, Microplate screening, Automated liquid handling platforms.
These approaches provide high accuracy and reproducibility and are widely used for both random mutagenesis libraries and site-saturation libraries.
Microplate Screening: Reliable and Flexible
Microplate-based screening remains one of the most commonly used approaches due to:
With robotic liquid handling and high-throughput purification technologies, thousands to millions of variants can be evaluated efficiently.
However, screening throughput is still limited compared with ultra-high-throughput technologies.
Droplet-Based Screening: Compartmentalizing Individual Variants
Beyond conventional tube-based and microplate screening, water-in-oil (W/O) droplets provide an alternative strategy to physically compartmentalize individual enzyme variants.
This concept was first applied in 1998 for the screening of methyltransferase variants. In this approach, each DNA molecule, together with the required components for protein expression, was encapsulated into an individual droplet.
After expression, active methyltransferase variants modified the target DNA molecules, protecting them from restriction enzyme digestion. This preserved the biotin label at the 3′ end of the DNA molecules, allowing subsequent purification and enrichment of active variants.
Using this droplet-based screening strategy, functional methyltransferase variants were successfully identified from a simulated library containing 10⁷ variants, demonstrating the potential of compartmentalized systems for ultra-high-throughput enzyme screening.
Figure 2. Screening of HaeIII Methyltransferase
(Image source: doi: 10.1038/nbt0798-652)
Compartmentalized Screening: Bringing High-Throughput Evolution to the Next Level
To overcome throughput limitations, researchers developed compartment-based screening technologies that physically separate individual variants.
CSR: Compartmentalized Self-Replication
The Compartmentalized Self-Replication (CSR) system was originally developed for DNA polymerase evolution.
In CSR:
- Individual enzyme variants are encapsulated in microreactors.
- Enzyme activity directly determines amplification efficiency.
- High-performing variants become enriched after replication.
CSR has been successfully applied to improve: Taq DNA polymerase, Pfu DNA polymerase, KOD polymerase, Bst DNA polymerase
However, its application is mainly limited to enzymes that can be connected to DNA amplification processes.
Figure 3. Compartmentalized Self-Replication (CSR) System
(Image source: doi: 10.1073/pnas.071052198)
Droplet Sorting — FADS and Beyond
When you need raw throughput, droplet-based sorting is where it's at.
FADS (Fluorescence-Activated Droplet Sorting) combines the precision of flow cytometry with the compartmentalization of microfluidic droplets. Cells and substrate are dispersed in an aqueous phase and injected into a PDMS microfluidic chip. An orthogonal oil phase shears the stream into uniform 20–50 μm droplets — each one a tiny bioreactor.
After incubation, catalytic activity inside the droplet triggers measurable changes: fluorescence, pH shift, turbidity, or accumulation of a specific compound. Droplets exceeding a set threshold are deflected by electric fields or air pulses into a collection tube.
Key advantages:
- Direct product detection — accurately reflects real enzyme performance
- Picoliter-scale reactors — cuts reagent costs by up to ~10⁶-fold
- Throughput up to 10⁸ droplets/day
- Modular chip design — adaptable to diverse screening scenarios
Derivative systems like AADS, BADS, and MADS extend the same principle with modified detection strategies (absorbance, bioluminescence, etc.).
One practical note: since cells need to be lysed inside the droplet, lysozyme or chemical lysis reagents are typically re-injected after droplet formation to prevent premature cell breakage.
Figure 4. Fluorescence-Activated Droplet Sorting (FADS)
(Image source: doi: 10.1016/j.tibs.2021.11.001)
Comparison of Directed Evolution Screening Technologies
|
Screening Location |
Method |
Selection Principle |
Advantages |
Limitations |
|
In vivo |
Single clone screening |
Growth advantage or phenotype change |
Simple operation, low cost |
Limited throughput; cellular effects may interfere |
|
In vivo |
PACE/PANCE |
Enzyme activity linked to phage propagation |
Continuous evolution, rapid enrichment |
Limited enzyme compatibility |
|
In vitro |
Microplate screening |
Direct enzyme activity measurement |
High accuracy and reproducibility |
Moderate throughput |
|
In vitro |
CSR |
Activity-driven DNA enrichment |
High throughput, suitable for polymerases |
Limited application range |
|
In vitro |
FADS/FACS-based sorting |
Functional phenotype separation |
Ultra-high throughput and high sensitivity |
Requires specialized platforms |
ZymeEditor™: Enabling Next-Generation Enzyme Engineering
Developing optimized enzymes requires not only advanced screening technologies but also integrated engineering strategies.
Powered by years of expertise in molecular enzyme engineering, Yeasen ZymeEditor™ provides customized enzyme evolution solutions by integrating multiple advanced technologies:
- FADS (Fluorescence-Activated Droplet Sorting)
- MTPS (Microplate Screening Technology)
- CSR (Compartmentalized Self-Replication)
- Computer-aided rational design
These technologies have been successfully applied to enzyme development for:
- Molecular diagnostics
- NGS library preparation
- Biotechnology applications
- Pharmaceutical research
By integrating advanced screening technologies with enzyme engineering expertise, Yeasen ZymeEditor™ empowers researchers and industries to discover and develop better enzymes for tomorrow’s applications.